Conditionally Toxic Proteins - Schein, Catherine H
136,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
68 °P sammeln
  • Gebundenes Buch

Human health depends upon access to high-quality proteins for our diet and pharmaceutical use. This book deals with the nature of toxicity as it applies to proteins in food and drugs.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Human health depends upon access to high-quality proteins for our diet and pharmaceutical use. This book deals with the nature of toxicity as it applies to proteins in food and drugs.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Catherine H. Schein earned a BA from the University of Pennsylvania in Biochemistry, a MSc from the Massachusetts Institute of Technology in Biochemical Engineering and a PhD from the Swiss Federal Institute of Technology (Zürich) in Technical Microbiology, with thesis projects on hemoglobin and the extracellular proteins of pathogenic Streptococci. Her interest in conditionally toxic proteins began while in a blood lab at a major hospital, which introduced her to blood groupings, leukemias and other blood diseases. Watching a young cousin go into anaphylactic shock after eating a nut (he survived but does his own cooking) led to her work on determining why seemingly innocuous proteins in food and pollens can cause extremely negative reactions in certain people. She produced pharmaceutical proteins, interferons (IFN) and other cytokines, at the industrial scale, for treating infections and cancers. During this work, she developed methods to prevent the aggregation of proteins, which have been used to produce thousands of other proteins for research and medical use. After transitioning to academic research, she studied interactions of IFN with ribonucleases and other cellular proteins, inhibitors of viral proteins and bacterial virulence factors, and distinguishing properties of allergenic proteins. She also studied inhibitors of aggregation of human proteins that form plaques in the brain characteristic of Alzheimer and other neurodegenerative diseases. This book reflects a central principle common to all these projects: that valuable pharmaceutical and food proteins can also be toxins, depending on context.